Salestools LogoSalestools
Agentes IA de Salestools
Soluciones
Recursos
Empresa
Precios
Salestools Logo

Salestools

El agente IA #1 para equipos de ventas y Go-to-Market. Vende más, más rápido, con menos esfuerzo.

Producto

  • Agentes de ventas IA
  • Datos de intención
  • Datos tecnológicos
  • Seguimiento de visitantes
  • Co-Pilot
  • Venta social

Soluciones

  • Servicio al cliente
  • Comercio electrónico
  • SaaS
  • Empresarial
  • Pequeña empresa

Recursos

  • El informe
  • Documentación
  • Referencia de API
  • Centro de ayuda
  • Blog
  • Casos de estudio
  • Webinars

Empresa

  • Acerca de
  • Carreras
  • Prensa
  • Contacto
  • Socios

Nuestras ubicaciones

  • Nueva York, HQ
  • Bucarest, laboratorio de investigación IA
  • Zug, Suiza

© 2026 Salestools. Todos los derechos reservados.

Términos de datos y seguridadPolítica de privacidadTérminos de servicioAcceptable Use
Todos los sistemas operativos
Salestools LogoSalestools
Agentes IA de Salestools
Soluciones
Recursos
Empresa
Precios
Back to Reports
Fundraising

Labelbox

Labelbox Raises $110M in Series E

San Francisco, CAOctober 10, 20252 min read
Employees
180+

Labelbox Raises $110M in Series E


Labelbox has successfully raised $110M in a Series E at a $1B valuation led by SoftBank Vision Fund 2, Andreessen Horowitz.


Company Overview


Labelbox is a AI/ML company headquartered in San Francisco, CA, founded in 2018 with 180+ employees.


Training data platform for computer vision and NLP


Fundraising Details


  • Amount Raised: $110M
  • Round Type: Series E
  • Valuation: $1B
  • Date: 2025-10-10
  • Investors: SoftBank Vision Fund 2, Andreessen Horowitz

About Labelbox


Training data platform for computer vision and NLP The company is positioned in the AI/ML sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: San Francisco, CA
  • Founded: 2018
  • Team Size: 180+
  • Industry: AI/ML

What This Means


This funding round demonstrates strong investor confidence in Labelbox's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The AI/ML sector continues to attract significant investment as companies innovate to meet evolving market demands. Labelbox's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $1B valuation marks an important milestone for Labelbox, positioning the company among notable players in the AI/ML industry.


Looking Ahead


With this new capital, Labelbox is well-positioned to execute on its growth strategy and continue building innovative solutions in the AI/ML space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-10-10. For more information about Labelbox, visit their headquarters at San Francisco, CA.

Company Info

Headquarters
San Francisco, CA
Founded
2018
Team Size
180+

Topics

Fundraising(2912)AI/ML(484)Series ELabelbox

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free